Literature DB >> 9421091

Increased E-cadherin expression in ovarian surface epithelium: an early step in metaplasia and dysplasia?

S L Maines-Bandiera1, N Auersperg.   

Abstract

Ovarian surface epithelium (OSE), the source of common epithelial carcinomas, is a simple mesothelium that during carcinogenesis acquires complex epithelial characteristics normally found in tubal, endometrial, and endocervical epithelia. These characteristics include the intercellular adhesive molecule E-cadherin. We examined cryostat sections of 12 normal ovaries by immunofluorescence and immunocytochemistry to determine whether E-cadherin is a component of normal OSE that is retained in ovarian cancers or whether it, like many other epithelial characteristics, is acquired in the course of metaplasia and neoplastic progression. E-cadherin expression by OSE varied with its location within the ovary and with cell shape. It was present inconsistently on the ovarian surface but was increased in surface invaginations and particularly in epithelial inclusion cysts. Independent of location, E-cadherin was most prominent in columnar, variable in cuboidal, and absent in flat OSE. This relationship to cell morphology accounts for the increased E-cadherin expression in inclusion cysts, which are sites of frequent metaplastic and dysplastic changes. These results suggest that the morphologic variation of OSE reflects differences in E-cadherin-mediated intercellular adhesion. Thus, the appearance of this adhesion molecule in columnar OSE may represent an early step in the increased commitment to epithelial phenotypes that accompanies metaplasia and neoplastic progression of OSE.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9421091     DOI: 10.1097/00004347-199707000-00010

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  22 in total

1.  Metaplastic changes in cultured human ovarian surface epithelium.

Authors:  A S Wong; P C Leung; S L Maines-Bandiera; N Auersperg
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-10       Impact factor: 2.416

2.  Comparison of c-met expression in ovarian epithelial tumors and normal epithelia of the female reproductive tract by quantitative laser scan microscopy.

Authors:  D Huntsman; J H Resau; E Klineberg; N Auersperg
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

3.  E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium.

Authors:  N Auersperg; J Pan; B D Grove; T Peterson; J Fisher; S Maines-Bandiera; A Somasiri; C D Roskelley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

4.  Sequential molecular and cellular events during neoplastic progression: a mouse syngeneic ovarian cancer model.

Authors:  Paul C Roberts; Emilio P Mottillo; Andrea C Baxa; Henry H Q Heng; Nicole Doyon-Reale; Lucie Gregoire; Wayne D Lancaster; Raja Rabah; Eva M Schmelz
Journal:  Neoplasia       Date:  2005-10       Impact factor: 5.715

5.  Epithelial-mesenchymal interconversions and the regulatory function of the ZEB family during the development and progression of ovarian cancer.

Authors:  D I Wu; Lei Liu; Chengcheng Ren; Dan Kong; Pengqi Zhang; Xiaoming Jin; Tianzhen Wang; Guangmei Zhang
Journal:  Oncol Lett       Date:  2016-01-08       Impact factor: 2.967

6.  Increased incidence of endometrioid tumors caused by aberrations in E-cadherin promoter of mismatch repair-deficient mice.

Authors:  Irina V Kovtun; Kimberly J Harris; Aminah Jatoi; Dragan Jevremovic
Journal:  Carcinogenesis       Date:  2011-05-05       Impact factor: 4.944

Review 7.  New insights into the pathogenesis of serous ovarian cancer and its clinical impact.

Authors:  Keren Levanon; Christopher Crum; Ronny Drapkin
Journal:  J Clin Oncol       Date:  2008-10-14       Impact factor: 44.544

Review 8.  Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.

Authors:  Masaki Mandai; Ken Yamaguchi; Noriomi Matsumura; Tsukasa Baba; Ikuo Konishi
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

9.  Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition.

Authors:  Thuy-Vy Do; Lena A Kubba; Hongyan Du; Charles D Sturgis; Teresa K Woodruff
Journal:  Mol Cancer Res       Date:  2008-05       Impact factor: 5.852

10.  Ovarian cancer mouse models: a summary of current models and their limitations.

Authors:  Miranda Y Fong; Sham S Kakar
Journal:  J Ovarian Res       Date:  2009-09-28       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.